How to File a Patent Internationally: The PCT Guide
Last revised:
April 19, 2026
A patent granted in one country protects you only in that country. A US patent does not stop a Chinese manufacturer from copying your invention. A European patent does not prevent a Brazilian competitor from producing and selling the same product in South America. If your invention has global commercial potential, international patent protection is not optional — it is essential.
The Patent Cooperation Treaty (PCT) is the primary mechanism most inventors use to pursue international patent protection efficiently. Understanding how it works, what it costs, and when to use it is one of the most important strategic decisions in any inventor's journey.
The Core Problem PCT Solves
Without the PCT, protecting an invention in 10 countries would require 10 separate patent applications, filed in 10 different languages, complying with 10 different sets of rules, all within 12 months of the original filing date. The cost would be prohibitive for most inventors; the complexity, paralyzing.
The PCT — administered by the World Intellectual Property Organization (WIPO) in Geneva — solves this by allowing an inventor to file a single international application that simultaneously preserves the right to seek patent protection in more than 150 member countries. A single filing. A single set of formalities. Decades of deferred decisions about which countries to pursue.
What PCT Is — and What It Is Not
This distinction matters enormously, and it confuses many inventors.
The PCT does not grant international patents. There is no such thing as a "world patent" or an "international patent." Patents are always granted nationally — by the USPTO, by the EPO, by CNIPA, by the JPO — and are always enforced nationally.
What the PCT does is:
- Preserve your options — a single PCT application keeps the door open in more than 150 countries without requiring immediate national filings
- Extend your timeline — gives you up to 30 months from your priority date to decide which countries to enter, dramatically reducing the pressure to commit early
- Provide an international search report — a professional search of the prior art, with a written opinion on patentability, before you commit to expensive national filings
- Potentially simplify examination — many national offices give significant weight to a favourable international search report, which can accelerate or simplify their own examination
Think of the PCT as buying time and information before making major financial commitments to specific national markets.
The PCT Timeline
Phase 1: The International Phase
Month 0 — Priority filing Your journey begins with a national or provisional filing — typically a US provisional application or a national application in your home country. This establishes your priority date.
Month 12 — PCT filing deadline You must file your PCT application within 12 months of the priority date (or within 12 months of the first national filing if you did not file a provisional). The PCT application claims priority to the earlier filing, so your effective protection date remains at month 0.
The PCT application is filed with a Receiving Office (RO) — typically the national patent office of your home country (USPTO for US applicants, EPO for European applicants, etc.) or directly with WIPO.
Month 18 — International publication WIPO publishes the PCT application — making it publicly available worldwide. Publication occurs 18 months after the priority date regardless of when you filed the PCT application.
Month 16–22 — International Search Report (ISR) A designated International Searching Authority (ISA) — typically the USPTO, EPO, or other major patent office — searches the prior art and produces two documents:
- International Search Report (ISR): Lists the prior art found and categorises each reference as X (highly relevant), Y (relevant in combination), A (background), or other categories
- Written Opinion (WO): The examiner's preliminary assessment of novelty, inventive step, and industrial applicability — essentially, a first indication of whether your claims are likely to be granted
The ISR and Written Opinion are not binding on national offices, but they are influential. A favourable opinion significantly increases the likelihood and speed of national grants.
Optional: International Preliminary Examination (Chapter II) If the Written Opinion is unfavourable, or if you want to strengthen your application before national phase entry, you can request International Preliminary Examination (IPEA). This initiates a dialogue with an examiner — you can amend claims and argue against rejections — and results in an International Preliminary Report on Patentability (IPRP). Chapter II is optional but useful when the Written Opinion raises serious concerns.
Month 30 — National Phase Entry deadline The most critical deadline in the PCT process. By month 30 from your priority date, you must file applications in each national or regional office where you want patent protection. This means paying national filing fees, potentially translating the application into local languages, and engaging local patent attorneys.
Countries not entered by month 30 are permanently lost — you cannot go back.
Phase 2: The National Phase
After entering national phases, each country examines your application according to its own laws and procedures. From this point, your PCT application becomes a portfolio of individual national applications, each prosecuted separately.
The PCT international search report and Written Opinion typically accompany the national phase entry and are considered by each national examiner. A positive Written Opinion often leads to faster and smoother national examination.
Which Countries Are PCT Members?
More than 150 countries are PCT Contracting States as of 2026, covering virtually every significant market for manufactured goods. Key members include:
- Americas: United States, Canada, Brazil, Mexico, Colombia, Argentina, Chile
- Europe: All EU member states, United Kingdom, Switzerland, Norway, Turkey (note: individual EU countries, not the EU as a bloc — protection is obtained through the EPO regional system covering all EPC member states)
- Asia-Pacific: China, Japan, South Korea, India, Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, New Zealand
- Middle East: Saudi Arabia, UAE, Qatar, Egypt, Israel, Jordan
- Africa: South Africa, Morocco, Nigeria, Kenya, and many others (also covered by regional systems ARIPO and OAPI)
Notable non-members include Taiwan (files nationally only) and Argentina (partial participation).
Regional Patent Systems Within PCT
Several regions have their own patent offices that cover multiple countries through a single filing, operating within the PCT framework:
European Patent Office (EPO) A PCT application can designate the EPO, which upon grant issues a European patent that can be validated in up to 44 EPC member states. Validation in each state requires separate fees and, in some countries, translation into local languages. The Unitary Patent (introduced in 2023) now allows a single EPO grant to have unitary effect across 18 EU member states without separate validation.
African Regional Intellectual Property Organization (ARIPO) Covers 20 African member states. A single ARIPO filing (or PCT national phase entry via ARIPO) can protect an invention across member countries including Ghana, Kenya, Malawi, Tanzania, Uganda, Zambia, and Zimbabwe.
African Intellectual Property Organization (OAPI) Covers 17 French-speaking African countries including Cameroon, Côte d'Ivoire, Senegal, and Mali. An OAPI filing creates a single patent right effective across all member states simultaneously — unlike ARIPO, no separate national validation is needed.
Eurasian Patent Organization (EAPO) Covers 9 former Soviet states including Russia, Kazakhstan, Azerbaijan, and Belarus.
Gulf Cooperation Council (GCC) Patent Office A single GCC patent covers all 6 GCC member states: Saudi Arabia, UAE, Qatar, Bahrain, Kuwait, and Oman. The GCC Patent Office participates in the PCT system. For inventors targeting the Gulf market, a single GCC application is significantly more cost-effective than six separate national filings.
PCT Costs: A Realistic Breakdown
PCT is not cheap — but it is dramatically cheaper than the alternative of separate national filings in 12 months.
PCT Filing Costs (International Phase)
Reduced fees are available for applicants from developing countries and, in some cases, for individual inventors or small entities.
National Phase Entry Costs (Per Country)
National phase costs vary enormously by country. Rough estimates per jurisdiction:
Translation costs are a significant additional expense in countries requiring filings in local languages (Japan, China, Korea, most non-English-speaking nations).
Realistic total for US + Europe + China + Japan: $40,000–$80,000 over the life of prosecution. International patent protection is a serious investment and should be made strategically, targeting only markets where the commercial opportunity justifies the cost.
The Paris Convention: The Alternative Route
The PCT is not the only mechanism for international filing. The Paris Convention — the older international IP treaty — allows inventors to file directly in member countries within 12 months of the priority filing, claiming the same priority date.
The Paris Convention route makes more sense when you know exactly which 1–2 countries you want to protect in, you want to minimise upfront costs, and you do not need the extra time the PCT provides.
The PCT makes more sense when you are targeting 3 or more countries, want to defer decisions while testing the market, and value the international search report as early guidance on patentability.
Many inventors use both: file a PCT application for broad international preservation, and file directly in a priority country (often the US) for the fastest possible national examination.
Strategic Considerations: Which Countries to Enter
The national phase decision at month 30 is one of the most consequential in your patent strategy. Entering too many countries wastes money on markets that will never generate returns. Entering too few leaves your invention unprotected in markets where it will be manufactured or sold.
A framework for deciding:
Where will you sell? Protect the markets where your product will be sold commercially. Infringement occurs where a product is sold — not just where it is made.
Where will it be manufactured? If your invention will be manufactured in China or Vietnam, protecting manufacturing jurisdictions prevents competitors from producing locally for export.
Where are your competitors? If your main competitors are based in Germany, a European patent is strategically valuable even if you do not sell heavily in Europe — it can be used offensively against the competitor's home market operations.
Where are the largest markets? The US, China, Europe (via EPO), and Japan together represent the vast majority of global patent litigation and licensing activity.
What can you afford to maintain? Patents require maintenance fees over their lifetime in each country. A patent you cannot afford to maintain will lapse. Better to choose fewer countries strategically than to overextend and lose patents due to non-payment of maintenance fees.
PCT and Utility Models
The PCT system covers utility model protection in countries that have it — including China, Germany, and Japan. When entering the national phase in China, for example, you can choose to enter as an invention patent application or convert to a utility model application (faster and cheaper). This decision should be made with your local Chinese attorney based on the technology and your commercial timeline.
In Germany, the PCT national phase entry does not directly produce a Gebrauchsmuster (utility model) — these must be filed separately. However, a German utility model can be "branched off" from a pending German national phase application at any point during prosecution, providing rapid protection while the full invention patent is examined.
Common PCT Mistakes
Missing the 12-month PCT filing deadline. There is no extension. If your provisional was filed on 1 March 2025, your PCT must be filed by 1 March 2026. Miss it and you lose the ability to claim priority in all PCT member countries from that date.
Missing the 30-month national phase deadline. Countries not entered by month 30 are permanently lost. Calendar this date the moment you file your PCT.
Filing in too many countries. Enthusiasm leads inventors to designate countries they have no realistic commercial interest in. National phase entry and prosecution costs in 10 countries can exceed $200,000. Be strategic.
Ignoring translation requirements. Many national phase entries require certified translations of the full application. Translation of a long patent application in technical language is expensive ($5,000–$20,000 per language) and time-consuming. Budget and plan for this.
Not using the ISR strategically. An unfavourable Written Opinion is early warning — use it. Amend claims, request Chapter II examination, and reshape your application before committing to expensive national phase entries.
Sources
- WIPO - PCT International Patent System — Official PCT guide covering procedures, fees, timelines, and member states
- WIPO - Patent Cooperation Treaty Text — Full text of the PCT treaty and regulations
- WIPO - Paris Convention — The Paris Convention priority system for international patent filings
- European Patent Office — EPO procedures for PCT national phase entry and European patent prosecution
- GCC Patent Office — GCC regional patent office covering Saudi Arabia, UAE, Qatar, Bahrain, Kuwait, and Oman
Frequently Asked Questions
Can I file a PCT application myself without an attorney?
Yes, but it is significantly more complex than a national application. The USPTO and WIPO provide guidance for pro se PCT applicants. For inventors targeting multiple major markets with commercially significant inventions, professional assistance is strongly recommended.
Does the PCT extend my priority date?
No. The PCT preserves rights based on your original priority date. It does not create a new, later priority date. It simply extends the deadline by which you must enter national phases from 12 months to 30 months.
What if my ISR is completely negative?
A negative ISR is not fatal. It is a signal. You can amend claims to distinguish from the cited prior art, request Chapter II examination to dialogue with an examiner, or reassess whether national phase entry is worth pursuing. Many patents with initially negative search reports are eventually granted after claim amendment.
Can I add new claims or new matter during national phase?
Generally, you cannot add new matter (subject matter not disclosed in the original PCT application) during national phase. You can amend claims within the bounds of the original disclosure. Each national office has its own rules on the extent of permissible amendments.
Is the GCC Patent Office easy to use for Gulf-based inventors?
The GCC Patent Office, headquartered in Riyadh, accepts PCT national phase entries. For Gulf-based inventors, it is one of the most cost-effective filings available — a single application covering Saudi Arabia, UAE, Qatar, Bahrain, Kuwait, and Oman. Examination is conducted in Arabic and English.
This article is part of the iInvent Encyclopedia — the world's most comprehensive knowledge base for inventors. It is intended for educational purposes and does not constitute legal advice. For guidance specific to your situation, consult a qualified patent attorney.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.